Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Methotrexate × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 49 Burkitt Lymphoma 24 Leukemia, Myeloid, Acute 13 Myelodysplastic Syndromes 11 Leukemia, Biphenotypic, Acute 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia 8 Lymphoma, Mantle-Cell 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Medulloblastoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Osteosarcoma 4 Lymphoma 4 Leukemia, Myeloid, Accelerated Phase 4 Hematologic Neoplasms 4 Graft vs Host Disease 4 Blast Crisis 4 Urinary Bladder Neoplasms 3 Primary Myelofibrosis 3 Neoplasm Metastasis 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Juvenile 3 Thrombocythemia, Essential 2 Rhabdoid Tumor 2 Polycythemia Vera 2 Neoplasm, Residual 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡